Together our data suggest that remotely increasing ACKR2 expression levels limits development of cutaneous inflammatory responses and, therefore, highlight a potential therapeutic role in psoriasis and other inflammatory diseases for agents capable of inducing ACKR2 expression. Here, ACKR2 is linked to psoriasis.